Background: Forensic autopsy strategies may improve differential diagnostics both post-mortem and ante-mortem and aid in clinical settings concerning preventive efforts for premature mortality. Excess mortality and reduced life expectancy affect persons with severe mental illnesses (SMI) for multi-faceted reasons that remain controversial. Somatic conditions, medical treatment and lifestyle diseases, which are primarily examined in the living, contribute to premature deaths. The underlying pathophysiological mechanisms are unclear, though, and the benefits of a focused, standardised autopsy remain unproven. We have developed and implemented an optimised molecular-biological autopsy for deceased persons with SMI. Our aim is to map the occurrence of 1) somatic diseases and organ changes; 2) metabolic syndrome; 3) use and abuse of alcohol, pharmaceuticals and psychoactive substances; 4) pharmacokinetic and pharmacodynamic factors in the metabolism of pharmaceuticals; and 5) genetic variations (acquired and/or congenital) in sudden cardiac death. Additionally, we hope to contribute to diagnostic treatments and preventive measures to benefit those living with SMI. Methods: SURVIVE: let the dead help the living is a prospective, autopsy-based study on 500 deceased persons with SMI subjected to forensic autopsies under the Danish Act on Forensic Inquests and Autopsy. The autopsies followed an extended, standardised autopsy protocol comprised of whole-body computed tomography scanning, magnetic resonance imaging of the heart and brain and an extended forensic autopsy, including a wide panel of analyses (toxicology, microbiology, genetics, histology and biochemical analysis). Additionally, post-mortem data were linked to ante-mortem health data extracted from Danish national health registers. Discussion: The SURVIVE autopsy procedure, including tissue sampling and bio banking, has been shown to be effective. We expect that the SURVIVE study will provide unique opportunities to unravel the mechanisms and causes of premature death in persons with SMI. We also expect that identifying prognostic biomarkers for comorbidities will contribute to prevention of premature deaths and comorbidities in persons with SMI.
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However, the underlying reasons for the reduced life expectancy among people with SMI are not sufficiently established. The known risk factors are varied and include cardiovascular diseases (CVD) and lifestyle-related factors, such as diabetes, metabolic syndrome (MetS), obesity, smoking and alcohol and substance use [12] [13] [14] . Persons with MetS have increased all-cause mortality and CVD mortality risk [15] . In addition to the risk of intoxication and the detrimental effects of polypharmacy, several antipsychotic and antidepressant pharmaceuticals have been associated with increased risk of sudden cardiac death (SCD) [16] [17] [18] .
The overall purpose of SURVIVE is to implement an autopsy strategy that can be used to investigate the known risk factors for premature death in a cohort of deceased persons suffering from SMI. These risk factors are lifestyleassociated factors [12] , MetS [19] , genetic disposition [20] , pharmaceuticals [21] and the (ab)use of alcohol and psychoactive substances [22] [23] [24] . The aim is to improve differential diagnostics in forensic medicine, clinical diagnostic tools, disease management and treatment in people with SMI within the healthcare sector. No major prospective or systematic autopsy studies have mapped the comorbidities, importance of known risk factors or causes of death in deceased persons with SMI.
RESEARCH QUESTIONS
The objective of SURVIVE is to develop and employ an optimised, molecularbiological autopsy model for deceased persons with SMI to identify the risk factors and causal pathways for sudden and unexpected death. 
METHODS AND DESIGN
Design
The SURVIVE study is a national Danish multicentre, prospective, autopsy- 
Study period
The study period was 1 May 2013-31 April 2015, and the study sample included 500 deceased individuals (Copenhagen=313, Aarhus=112, Odense=75).
Study population
Inclusion criteria
The project prospectively included all deceased who had known or suspected SMI undergoing forensic autopsy at one of Denmark's three departments of forensic medicine from the 1 st of May 2013 and until 500 decedents were included. Upon inclusion of each individual person in the SURVIVE study, the SURVIVE algorithm and workflow were activated.
Generally, during the medico-legal inquest, the police decided whether a forensic autopsy should be performed based on the Danish Health Act and the advice of a participating medical health officer or forensic pathologist.
The attending physician determined the presence of SMI or the suspicion of SMI at the time of the medico-legal examination based on information gathered from police reports, next of kin and statements from general practitioners. In some cases, the information was certain and These broad criteria were chosen to avoid missing decedents suffering from an SMI and to include an internal control group of the false positivesdecedents without SMI that underwent the same specialised autopsy.
detailed plan to contact the next of in was accordingly developed. Written information about the SURVIVE study, including the need for consent and instructions how to contact the research team by email or phone, was mailed by post to the next of kin no less than three months after an autopsy was performed. In the case of no reply, a follow-up phone call was made.
All information regarding consent, contact information of next of kin and other comments about the information process was recorded in a separate
Microsoft Access 2010™ (Microsoft®, Redmond, Washington, USA) database separate from the data registered for the research purposes on each individual case. Cases in which relatives did not give consent were excluded from SURVIVE. Obtaining consent was completed in May 2017, and the consent rate from next of kin was higher than 90%.
Blinding
All cases were assigned a unique project identification (ID) number (SURVIVE-ID) upon inclusion in the study. 
SURVIVE protocol
Post-mortem radiology
All cases were subjected to whole-body PMCT scanning before autopsy at a department of forensic medicine. Either a Siemens CT scanner Somatom Scanner Siemens Somatom Sensation 4, May-October 2013 Scanner Siemens Somatom Definition, 64 slice, October 2013-May 2015 
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In selected cases, PMCT angiography and PMMRI of the heart and brain were performed.
Extended autopsy algorithm
The standardised autopsy algorithm followed the most recent accredited standards from DANAK. The SURVIVE algorithm built on it by thoroughly describing the registration of physical parameters and anthropometric measurements and the dissection and sampling of each relevant organ (Table 5) , focusing on the dissection and registration of heart parameters ( Table 6 ). Dissection of the heart was performed according to international standards [25] .
The material needed for registration, sampling and data collection was supplied in an individually assigned cardboard box with a unique SURVIVE-ID. The cardboard box was suitable for the autopsy room and provided before the autopsy. Specifically assigned medical personnel performed all registrations before and during each autopsy (see tables 7-8).
Sampling
The location and sidedness (left or right) of the sample from each organ and tissue were standardised. In addition to the standard autopsy protocol, the samples included peripheral blood and tissue from skeletal muscles, liver, spleen, heart and brain; bone samples from the second lumbar vertebrae and the iliac crest; and hair samples. All tissue and fluid samples were collected in tubes without any additives (15 mL and 5mL, respectively).
The relevant samples were stored at -20°C or -80°C until analysis. Tissue for histopathological analyses was fixed in 4% formalin and then embedded in paraffin. Finally, blood was added to DNA filter paper (FTA™ Classic Card, Fitzco, Minneapolis, USA) and stored at room temperature for later analyses.
Sample analysis
Members of the steering group of the SURVIVE-study, who were all certified clinical and forensic pathologists, based histopathological description on a consensus decision. The forensic toxicological analysis after the autopsy was performed at all three forensic chemistry departments following the current DANAK standards under the international standard ISO/IEC 17025:2005.
All the toxicological analyses also adhered to an intersectional, approved standard for medication and drug types, analyses matrices and intoxication levels. The analyses comprised screening and quantification of prescribed pharmaceuticals and illicit psychoactive substances, including active metabolites from several samples ( Table 9) .
Additional forensic biochemical, microbiological and molecular biology analyses (tables 9 and 10) were performed, including but not limited to post-mortem measurements of blood total cholesterol levels, triglycerides, glycated haemoglobin (HbA1c) and urine-albumin/creatinine ratio.
Other data sources
The 500 cases were supplemented with register-based data from the Danish national health registers (see Table 11 ) including, but not limited to: information on dispensed prescription medication, contacts with primary health care providers, admissions to hospitals including emergency wards, ambulatory functions and long term admission, use of involuntary commitment in the psychiatric health care system and registration in substance use treatment facilities,
Study outcomes/SURVIVE-an umbrella for several studies
SURVIVE has yielded extensive data and bio sampling serving as entry points for sub-projects relevant to premature death and comorbidities in the population with SMI. Furthermore, the SURVIVE study provides opportunities for the development and improvement of autopsy techniques. To answer the central research questions of the SURVIVE study, several PhD students Scanner Siemens Somatom Spirit Dual Slice, May 2013-May 2015. Each CT scanner was equipped with a calibration phantom containing different concentrations of hydroxyapatite. The phantoms were supplied by the firm Image Analysis, Inc. Additionally, the CT scanner in Aarhus was equipped with a calibration phantom specifically designed for the measurement of bone mass density by the firm QCT Pro, Mindways Software. Heart (see Table 6 ) a h x l x d: height x length x depth VOLUME (Table 12) .
Statistical considerations
For 
LIMITATIONS AND CONCERNS
The medicolegal system setting and the Danish Act on Forensic Inquests limit the number of included cases with SMI. The police decide whether further investigations warrant forensic autopsy. Consequently, the SURVIVE study does not include the deaths of persons with SMI the police decide not to refer for forensic autopsies. Deaths not subjected to legal inquest, such as hospital deaths and clinical autopsies performed in hospital settings, are not included. The included cases thus are subject to selection bias. The SURVIVE inclusion criteria are very broad to ensure forming a sufficiently large group of controls that do not fulfil the criteria for a verified diagnosis within the ICD-10 F2 or F3 sections.
SURVIVE is the first Danish forensic research project requiring consent.
The setup of the medico-legal system and autopsies required immediate sampling for the study, and it was not possible to ask relatives for informed consent before the autopsies. When contacted several months after the autopsies, many relatives gave consent but also expressed a degree of re-traumatisation by the contact in a situation of grief. Although the final study group of 500 is high by forensic pathology standards, the study group Tissue for microscopy (see Table 8 )
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is small compared to studies among the living [6, 26, 27] . This poses some constraints for the selection of individual research questions. Identifying the mechanisms underlying premature death in persons suffering from schizophrenia or severe depression, a registry-based study
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